What is the total authorization amount after this increase?

The total available authorization is $700 million. This consists of the previously authorized amount plus the new $510 million authorization announced on September 10, 2026. The company will have $600 million remaining after completing current repurchase programs expected in 2026.

How much will the company spend on buybacks in 2026?

Curtiss-Wright expects annual share repurchases of approximately $460 million in 2026, in line with the prior year's record $466 million program. This includes the $100 million immediate execution via the new 10b5-1 plan, plus additional tranches previously announced in August 2026.

What does a 10b5-1 plan mean for execution?

A 10b5-1 trading plan is a pre-arranged program that allows the company to repurchase shares according to a preset schedule and formula, independent of management trading windows or market conditions. This provides certainty and complies with securities law by removing insider-trading concerns from the buyback process.

How much has Curtiss-Wright returned to shareholders via buybacks historically?

Since 2021, the company has returned over $1.5 billion to shareholders through share repurchases. The company is executing repurchases alongside a quarterly dividend of $0.26 per share, demonstrating a balanced approach to capital returns.

What prompted this authorization increase?

CEO Lynn M. Bamford stated that the increase reflects the Board's confidence in the company's Pivot to Growth strategy, healthy balance sheet, and strong financial outlook. The company is combining near-record buybacks with disciplined investment in R&D and capital expenditures as strategic accelerators to organic growth.

CW 8-K Filed 2026-09-14 New authorization

Curtiss-Wright authorizes $700M share repurchase program

Board increases total authorization by $510M and launches $100M immediate execution via 10b5-1 plan.

Authorization$510M

Remaining$600M

Mechanism10b5-1 plan

What the filing says

Curtiss-Wright Corporation's Board of Directors has authorized an additional $510 million for share repurchases, increasing the total available authorization to $700 million. Under this expanded authorization, the company will immediately execute $100 million in repurchases via a 10b5-1 program. The company previously executed two separate $100 million expansions in August 2026 and an additional $100 million in conditional repurchases, while continuing a $60 million program initiated in January 2026 to offset dilution from compensation plans.

The company expects annual share repurchases of approximately $460 million in 2026, in line with the prior year's record $466 million buyback program. Since 2021, Curtiss-Wright has returned over $1.5 billion to shareholders through repurchases. Upon completion of the current programs, the company will have $600 million remaining in open repurchase authorization entering 2027.

The authorization reflects the Board's confidence in the company's "Pivot to Growth" strategy, healthy balance sheet, and strong financial outlook. CEO Lynn M. Bamford noted that momentum at Curtiss-Wright is enabling record financial performance and near-record share repurchases while maintaining disciplined capital allocation and accelerating investment in research and development and capital expenditures.

Curtiss-Wright Corporation (NYSE: CW) today announced that the Board of Directors has authorized an additional $510 million for future share repurchases, increasing the total available authorization to $700 million. Under this new authorization, the Company will repurchase $100 million in additional shares immediately via a 10b5-1 program. — CURTISS WRIGHT CORP 8-K filing · View on SEC EDGAR →

What this means

Curtiss-Wright's $510 million authorization increase brings its total repurchase authority to $700 million, with $100 million deployed immediately under a 10b5-1 trading plan. The company expects to repurchase approximately $460 million in 2026, maintaining near-record buyback pace while managing multiple concurrent repurchase tranches. With $600 million remaining authorization post-completion, the company has substantial flexibility for future capital returns. Over five years (2021–2026), cumulative repurchases exceed $1.5 billion, representing a material effort to offset share dilution and return capital during a period of strong operational performance.

Frequently asked questions

What is the total authorization amount after this increase?: The total available authorization is $700 million. This consists of the previously authorized amount plus the new $510 million authorization announced on September 10, 2026. The company will have $600 million remaining after completing current repurchase programs expected in 2026.
How much will the company spend on buybacks in 2026?: Curtiss-Wright expects annual share repurchases of approximately $460 million in 2026, in line with the prior year's record $466 million program. This includes the $100 million immediate execution via the new 10b5-1 plan, plus additional tranches previously announced in August 2026.
What does a 10b5-1 plan mean for execution?: A 10b5-1 trading plan is a pre-arranged program that allows the company to repurchase shares according to a preset schedule and formula, independent of management trading windows or market conditions. This provides certainty and complies with securities law by removing insider-trading concerns from the buyback process.
How much has Curtiss-Wright returned to shareholders via buybacks historically?: Since 2021, the company has returned over $1.5 billion to shareholders through share repurchases. The company is executing repurchases alongside a quarterly dividend of $0.26 per share, demonstrating a balanced approach to capital returns.
What prompted this authorization increase?: CEO Lynn M. Bamford stated that the increase reflects the Board's confidence in the company's Pivot to Growth strategy, healthy balance sheet, and strong financial outlook. The company is combining near-record buybacks with disciplined investment in R&D and capital expenditures as strategic accelerators to organic growth.

authorization aerospace-defense $700M 10b5-1-plan capital-return dividend

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.